RankingsPricing
  1. US-listed companies
  2. AGIOS PHARMACEUTICALS, INC.
  3. Financials
  4. Retained earnings

AGIOS PHARMACEUTICALS, INC.AGIO

Market cap
$1.5B
P/E ratio
SummaryFinancials
Period EndRetained earnings (Million USD)YoY (%)
Dec 31, 2024-149-81.90%
Dec 31, 2023-823+74.82%
Dec 31, 2022-471+97.09%
Dec 31, 2021-239-87.05%
Dec 31, 2020-1,843+21.59%
Dec 31, 2019-1,516+37.25%
Dec 31, 2018-1,105+38.41%
Dec 31, 2017-798+65.18%
Dec 31, 2016-483+69.72%
Dec 31, 2015-285+70.52%
Dec 31, 2014-167+47.16%
Dec 31, 2013-113

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)